United States

Bioanalytical Systems Inc (BASI.OQ)

BASI.OQ on NASDAQ Stock Exchange Capital Market

20 Jan 2017
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for BASI.OQ


Bioanalytical systems, Inc. is an international contract research company providing drug discovery and development services and analytical instruments. The Company operates in two segments: contract research services and research products. The contract research services segment provides research and development support on a... (more)
No analyst recommendations are available for BASI.OQ.


Beta: 0.73
Market Cap(Mil.): $7.62
Shares Outstanding(Mil.): 8.11
Dividend: --
Yield (%): --


  BASI.OQ Industry Sector
P/E (TTM): -- 44.85 30.38
EPS (TTM): -0.40 -- --
ROI: -29.14 -1.38 14.86
ROE: -40.84 -1.07 16.28

BRIEF-Bioanalytical Systems' CEO Jacqueline Lemke to resign

* Bioanalytical Systems - on Nov 2, Jacqueline Lemke informed board of her intent to resign from her positions of president and chief executive officer

Nov 08 2016

BRIEF-Bioanalytical Systems entered third forbearance agreement,fourth amendment to credit agreement-SEC filing

* Effective Sept 30, Co entered third forbearance agreement ,fourth amendment to credit agreement-SEC filing

Oct 03 2016

BRIEF-Basi Q3 loss per share $0.05

* Q3 revenue fell 17.8 percent to $5.053 million Source text for Eikon: Further company coverage:

Aug 11 2016

BRIEF-Bioanalytical Systems elects Larry Boulet as Board's chairman

* On July 28, company's board of directors voted unanimously to elect Larry Boulet as chairman of the board - SEC Filing Source text - (http://bit.ly/2aY61ZP) Further company coverage:

Aug 04 2016


Earnings vs. Estimates